The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden
Willis M, Svensson M, Löthgren M, Eriksson B, Berntsson A & Persson U
The European Journal of Health Economics, 2010; 11(6): 585-594
DOI: 10.1007/s10198-009-0215-9